Research Studies

Intensive Care Unit Randomised Trial Comparing Two Approaches to OXygen Therapy (UK-ROX)

Start Date
August 2021
End Date
May 2023
Co-ordinated by
ICNARC
Local PI
Dr Daniel Harvey
Lead Research Practitioner
David Ford

Oxygen is one of the commonest drugs administered to patients in ICU. Despite this, there isn’t enough evidence to guide the clinical team in the use of oxygen in order to minimise potential harm from giving too little or too much oxygen. The aim of this study is to identify whether adults receiving mechanical ventilation and supplemental oxygen in ICU have better outcomes when they receive conservative oxygen therapy compared to usual oxygen therapy.

More information on the study can be found here: https://www.icnarc.org/Our-Research/Studies/Uk-Rox